Showing results 1 to 11 of 11
| Title | Author(s) | Issue Date | |
|---|---|---|---|
A detailed evaluation of the relationship between tricuspid regurgitation and liver stiffness measured by transient eastography Proceeding/Conference:Research Postgraduate Symposium, RPS 2015 | 2015 | ||
| 1999 | |||
Breaking liver disease chain by Chinese Medicines: evidences for preventing and treating hepatocellular carcinoma Proceeding/Conference:Meeting of Consortium for Globalization of Chinese Medicine, CGCM 2015 | 2015 | ||
Future prevention and treatment of chronic hepatitis B infection Journal:Journal of Clinical Gastroenterology | 2012 | ||
Metabolic dysfunction-associated steatotic liver disease is a risk factor for lower vaccine immunogenicity against SARS-COV-2 omicron variant among three-dose BNT162b2 recipients Proceeding/Conference:Medical Research Conference, the University of Hong Kong (20/01/2024-20/01/2024, , , Hong Kong) | 20-Jan-2024 | ||
MODELING SOLIDS WITH SWEEP PRIMITIVES. Journal:CIME. Computers in mechanical engineering | 1987 | ||
Multidisciplinary approaches in Chinese Medicines Research: case of Coptis Proceeding/Conference:5th Annual Meeting of GP-TCM Research Association-cum-summit on Compendium of Materia Medica and Innovative Drug Discovery in Chinese Medicine | 2016 | ||
NC MACHINING ALGORITHMS FOR CSG SOLIDS. Proceeding/Conference:American Society of Mechanical Engineers, Design Engineering Division (Publication) DE | 1987 | ||
New Exploration of Chinese Herbal Medicines in Hepatology Journal:Evidence-Based Complementary and Alternative Medicine | 2016 | ||
OCTREE APPROACH TO ROUGH MACHINING. Journal:Proceedings of the Institution of Mechanical Engineers. Part B. Management and engineering manufacture | 1987 | ||
Sodium-glucose cotransporter-2 inhibitors associated with lower risk of hepatocellular carcinoma and hepatic decompensation in type 2 diabetes mellitus Proceeding/Conference:Digestive Disease Week 2024 (18/05/2024-21/05/2024, , , Washington, DC, USA) | 18-May-2024 |